CS
AGTC

Credit Suisse’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Credit Suisse’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-36,554
Closed -$186K – 4285
2017
Q2 		$186K Buy
36,554
+9,444
+35% +$53K ﹤0.01% 3635
2017
Q1 		$187K Buy
27,110
+2,662
+11% +$20.8K ﹤0.01% 3632
2016
Q4 		$229K Buy
24,448
+14,048
+135% +$127K ﹤0.01% 3759
2016
Q3 		$101K Sell
10,400
-254
-2% -$3.43K ﹤0.01% 3931
2016
Q2 		$151K Sell
10,654
-3,193
-23% -$49.8K ﹤0.01% 3968
2016
Q1 		$193K Buy
+13,847
New +$203K ﹤0.01% 3700

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse's AGTC Position: Q3 2017 in Review

Credit Suisse sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2017, closing a stake of 36,554 shares — an estimated $186K sold.

Credit Suisse first reported a position in AGTC in Q1 2016 and held it in 6 quarters. The position peaked at $229K in Q4 2016. 67 funds tracked by Wall St. Rank hold AGTC as of Q3 2017.

  • Credit Suisse reported no remaining Applied Genetic Technologies Corporation position as of Q3 2017 after selling out during the quarter.
  • Credit Suisse sold 36,554 Applied Genetic Technologies Corporation shares in Q3 2017, an estimated $186K.
  • Credit Suisse first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and held it in 6 quarters.
  • Credit Suisse's Applied Genetic Technologies Corporation position peaked at $229K in Q4 2016.
  • 67 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2017.

Based on Credit Suisse's 13F filing for Q3 2017, filed 14 Nov 2017.